These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5999449)

  • 21. [Use of gelofusin in the clinics of the St. Petersburg's I.P. Pavlov State Medical University].
    Baryshev BA; Doĭnikov DN; Khabarova IG; Kovalev MG
    Vestn Khir Im I I Grek; 1998; 157(2):51-4. PubMed ID: 9691382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects.
    de Jonge E; Levi M; Berends F; van der Ende AE; ten Cate JW; Stoutenbeek CP
    Thromb Haemost; 1998 Feb; 79(2):286-90. PubMed ID: 9493577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On excretion of the plasma substitute solution "zhelatinol"].
    Znamenskaia TV
    Probl Gematol Pereliv Krovi; 1966 Jul; 11(7):37-42. PubMed ID: 6002179
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of different fluid-loading solutions on renal tubular cells in brain-dead dogs.
    Meduri G; Douguet D; Moukarzel M; Benoit G
    Transplant Proc; 1995 Aug; 27(4):2497-8. PubMed ID: 7544507
    [No Abstract]   [Full Text] [Related]  

  • 25. Distribution and clearance from the body of an oxypolygelatin plasma substitute determined by radioactive tracer study in chimpanzees.
    Muchmore E; Bonhard K; Kothe N
    Arzneimittelforschung; 1983; 33(11):1552-4. PubMed ID: 6686451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The duration of circulation in the vascular bed and elimination from the body of the blood substitute geosen].
    Bryzgina TM; Aleksiuk LI
    Fiziol Zh; 1975; 21(2):195-200. PubMed ID: 1126476
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the content and changes of serum proteins of the recipient after transfusion of the protein blood substitute (BK-8)].
    Alekseeva IN
    Ukr Biokhim Zh; 1965; 37(2):226-30. PubMed ID: 5869080
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemodilution, oxygen consumption, and recovery from surgical shock. --A study on the efficacy of different plasma substitutes.
    Dawidson I
    Ann Clin Res; 1981; 13 Suppl 33():44-7. PubMed ID: 7342843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle microcirculation and oxygenation in experimental intestinal shock: A study on the efficacy of different plasma substitutes.
    Dawidson I; Appelgren L; Gelin LE; Haglind E; Lung N
    Circ Shock; 1980; 7(4):435-45. PubMed ID: 7226434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Several properties of the blood substitute geossen].
    Spasokukotskiĭ IuA; Bryzgina TM
    Fiziol Zh; 1975; 21(2):267-9. PubMed ID: 1126486
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of a bovine stroma-free hemoglobin solution as a blood substitute.
    Feola M; Gonzalez H; Canizaro PC; Bingham D; Periman P
    Surg Gynecol Obstet; 1983 Nov; 157(5):399-408. PubMed ID: 6635908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood substitutes: where are we?
    Greenburg AG
    Surg Annu; 1983; 15():13-23. PubMed ID: 6353631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gelatin as a plasma substitute.
    LOCKWOOD JS
    Surg Gynecol Obstet; 1947 Jul; 85(1):114-6. PubMed ID: 20249255
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the effect of polyvinol, a plasma substitute, on liver function in dogs].
    Khlebnikova IM
    Patol Fiziol Eksp Ter; 1965; 9(2):70-1. PubMed ID: 5845155
    [No Abstract]   [Full Text] [Related]  

  • 35. The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption.
    ten Dam MA; Branten AJ; Klasen IS; Wetzels JF
    J Crit Care; 2001 Sep; 16(3):115-20. PubMed ID: 11689768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
    Caron A; Hacquard M; Audibert G; Cauchois G; Vigneron C; Stoltz JF; Longrois D; Menu P
    Clin Hemorheol Microcirc; 2006; 35(4):447-58. PubMed ID: 17148843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study and clinical results of the use of a new plasma substitute].
    SOAVE F; BIANCHI V; GALLO G; MUZZULINI G; RAMOINO L
    Minerva Chir; 1954 Mar; 9(6):237-44. PubMed ID: 13165112
    [No Abstract]   [Full Text] [Related]  

  • 38. Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substitute.
    Di Nicola M; Siena S; Bregni M; Belli N; Milanesi M; Ruffini PA; Malaffo F; Ravagnani F; Gianni AM
    Bone Marrow Transplant; 1996 Sep; 18(3):619-23. PubMed ID: 8879627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunological research on animals and humans treated with a new plasma substitute drawn from decomposed gelatin. I. General considerations and immunological study in animals].
    BEDARIDA G; MOREO GC
    Riv Emoter Immunoematol; 1962; 9():265-79. PubMed ID: 13970193
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experience with the use of gelofusin (gelatin) in anesthesiology, resuscitation and intensive care].
    Eremenko AA; Kuslieva EV
    Anesteziol Reanimatol; 2001; (3):58-61. PubMed ID: 11510363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.